Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
84.8M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
44.3M
-
Shares change
-
+44.3M
-
Total reported value, excl. options
-
$1.49B
-
Value change
-
+$1.49B
-
Number of buys
-
88
-
Price
-
$33.66
Significant Holders of Heartflow, Inc. - Common Stock (HTFL) as of Q3 2025
88 filings reported holding HTFL - Heartflow, Inc. - Common Stock as of Q3 2025.
Heartflow, Inc. - Common Stock (HTFL) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.3M shares
of 84.8M outstanding shares and own 52.26% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (12.4M shares), WELLINGTON MANAGEMENT GROUP LLP (4.88M shares), FMR LLC (4.73M shares), BAILLIE GIFFORD & CO (3.01M shares), Schusterman Interests, LLC (1.94M shares), VANGUARD GROUP INC (1.45M shares), Capital International Investors (1.3M shares), BAMCO INC /NY/ (1.24M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.21M shares), and LORD, ABBETT & CO. LLC (1.13M shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.